Is lamotrigine (anticonvulsant medication) safe?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Lamotrigine is generally considered safe when used appropriately under medical supervision, but it does carry some risks that require careful management. It's an effective anticonvulsant medication used to treat epilepsy and bipolar disorder, with a relatively favorable side effect profile compared to some other medications in its class. The most serious concern with lamotrigine is the risk of developing a severe skin rash, particularly Stevens-Johnson syndrome or toxic epidermal necrolysis, which occurs in approximately 0.3-1% of patients 1. This risk is significantly reduced by following the recommended slow titration schedule, typically starting at 25mg daily for two weeks, then 50mg daily for two weeks, before gradually increasing to therapeutic doses (usually 100-400mg daily for most adults, divided into one or two doses).

Some key points to consider when using lamotrigine include:

  • The risk of serious rash is higher in children, patients also taking valproate, and those who escalate the dose too quickly 1.
  • Common side effects include headache, dizziness, double vision, and coordination problems, which are usually mild and temporary.
  • Lamotrigine has minimal effects on cognition and weight, making it better tolerated than many alternatives.
  • Regular monitoring by a healthcare provider is essential, especially during the first few months of treatment.
  • Patients should immediately report any rash, fever, or flu-like symptoms to their doctor, as these could indicate a serious reaction requiring immediate discontinuation.

In terms of loading doses, a single oral load of 6.5 mg/kg can be considered if the patient has been on lamotrigine for more than 6 months without a history of rash or intolerance and has only been off lamotrigine for less than 5 days 1. However, it's crucial to weigh the benefits and risks of loading doses on a case-by-case basis, considering the individual patient's medical history and current condition.

Overall, lamotrigine can be a valuable treatment option for patients with epilepsy and bipolar disorder, but its use requires careful consideration of the potential risks and close monitoring to minimize adverse effects.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Safety of Lamotrigine

The safety of lamotrigine, an anticonvulsant medication, has been evaluated in several studies.

  • Lamotrigine is generally well-tolerated, with a low incidence of adverse effects 2, 3, 4, 5.
  • Common side effects include headache, insomnia, and drowsiness 2, 5.
  • Serious rash is a rare but potentially serious side effect, occurring in approximately 0.1% of patients 5.
  • Long-term use of lamotrigine has been shown to be safe and well-tolerated, even at high maintenance doses 4.

Psychiatric Symptoms

Lamotrigine has been associated with psychiatric symptoms, including:

  • Affective switches 3
  • Full acute psychotic episodes 3
  • Hallucinations 3 However, these symptoms are rare and clinicians should be aware of the risk when prescribing lamotrigine 3.

Pharmacokinetics

Lamotrigine has a favorable pharmacokinetic profile, with:

  • Rapid absorption and peak concentrations reached within 3 hours 6
  • High bioavailability (approximately 98%) 6
  • Linear pharmacokinetics and a half-life of 22.8 to 37.4 hours in healthy volunteers 6
  • Metabolism primarily through glucuronidation, with 43 to 87% of the dose recovered in the urine 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lamotrigine in the treatment of bipolar disorder.

Expert opinion on pharmacotherapy, 2005

Research

Lamotrigine clinical pharmacokinetics.

Clinical pharmacokinetics, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.